|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24,100 KRW | -0.62% |
|
+0.42% | +1.05% |
| 2023 | CKD Bio Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
| 2023 | CKD Bio Corp.(KOSE:A063160) dropped from S&P Global BMI Index | CI |
CKD Bio Corp. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 0.00066 million compared to KRW 0.00051 million a year ago.
Net loss was KRW 2,905.32 million compared to KRW 1,204.55 million a year ago. Basic loss per share from continuing operations was KRW 530 compared to KRW 220 a year ago. Basic loss per share was KRW 530 compared to KRW 220 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.05% | 98.15M | |
| +31.88% | 694B | |
| +29.49% | 593B | |
| -1.67% | 371B | |
| +19.48% | 331B | |
| +6.65% | 290B | |
| +14.23% | 239B | |
| -3.11% | 209B | |
| +10.05% | 209B | |
| +8.26% | 169B |
CKD BIO CORP. 
